Form 8-K - Current report:
SEC Accession No. 0001213900-25-024752
Filing Date
2025-03-18
Accepted
2025-03-18 06:05:55
Documents
13
Period of Report
2025-03-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0234727-8k_incannex.htm   iXBRL 8-K 27298
  Complete submission text file 0001213900-25-024752.txt   202951

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ixhl-20250313.xsd EX-101.SCH 3024
3 XBRL LABEL FILE ixhl-20250313_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE ixhl-20250313_pre.xml EX-101.PRE 22365
15 EXTRACTED XBRL INSTANCE DOCUMENT ea0234727-8k_incannex_htm.xml XML 3787
Mailing Address 8 CENTURY CIRCUIT STE. 105 NORWEST NSW C3 2153
Business Address 8 CENTURY CIRCUIT STE. 105 NORWEST NSW C3 2153 61 409 840 786
Incannex Healthcare Inc. (Filer) CIK: 0001873875 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-41106 | Film No.: 25746400
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)